These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 22994227

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas.
    Kunte H, Busch MA, Trostdorf K, Vollnberg B, Harms L, Mehta RI, Castellani RJ, Mandava P, Kent TA, Simard JM.
    Ann Neurol; 2012 Nov; 72(5):799-806. PubMed ID: 23280795
    [Abstract] [Full Text] [Related]

  • 3. Drugs acting on SUR1 to treat CNS ischemia and trauma.
    Simard JM, Woo SK, Bhatta S, Gerzanich V.
    Curr Opin Pharmacol; 2008 Feb; 8(1):42-9. PubMed ID: 18032110
    [Abstract] [Full Text] [Related]

  • 4. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.
    King ZA, Sheth KN, Kimberly WT, Simard JM.
    Drug Des Devel Ther; 2018 Feb; 12():2539-2552. PubMed ID: 30147301
    [Abstract] [Full Text] [Related]

  • 5. Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8.
    Woo SK, Kwon MS, Geng Z, Chen Z, Ivanov A, Bhatta S, Gerzanich V, Simard JM.
    J Cereb Blood Flow Metab; 2012 Mar; 32(3):525-36. PubMed ID: 22086197
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM, Tucker SJ, Seino S, Ashcroft FM.
    Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel approaches to the primary prevention of edema after ischemia.
    Sheth KN.
    Stroke; 2013 Jun; 44(6 Suppl 1):S136. PubMed ID: 23709712
    [No Abstract] [Full Text] [Related]

  • 10. Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats.
    Zhou Y, Fathali N, Lekic T, Tang J, Zhang JH.
    Brain Res; 2009 May 13; 1270():131-9. PubMed ID: 19306849
    [Abstract] [Full Text] [Related]

  • 11. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.
    Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, Tsymbalyuk N, West GA, Gerzanich V.
    Nat Med; 2006 Apr 13; 12(4):433-40. PubMed ID: 16550187
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).
    Hambrock A, de Oliveira Franz CB, Hiller S, Osswald H.
    J Pharmacol Exp Ther; 2006 Mar 13; 316(3):1031-7. PubMed ID: 16306272
    [Abstract] [Full Text] [Related]

  • 14. Glibenclamide in cerebral ischemia and stroke.
    Simard JM, Sheth KN, Kimberly WT, Stern BJ, del Zoppo GJ, Jacobson S, Gerzanich V.
    Neurocrit Care; 2014 Apr 13; 20(2):319-33. PubMed ID: 24132564
    [Abstract] [Full Text] [Related]

  • 15. Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.
    Simard JM, Tsymbalyuk O, Ivanov A, Ivanova S, Bhatta S, Geng Z, Woo SK, Gerzanich V.
    J Clin Invest; 2007 Aug 13; 117(8):2105-13. PubMed ID: 17657312
    [Abstract] [Full Text] [Related]

  • 16. Glibenclamide for the treatment of ischemic and hemorrhagic stroke.
    Caffes N, Kurland DB, Gerzanich V, Simard JM.
    Int J Mol Sci; 2015 Mar 04; 16(3):4973-84. PubMed ID: 25749474
    [Abstract] [Full Text] [Related]

  • 17. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke.
    Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V.
    Stroke; 2009 Feb 04; 40(2):604-9. PubMed ID: 19023097
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner.
    Hambrock A, de Oliveira Franz CB, Hiller S, Grenz A, Ackermann S, Schulze DU, Drews G, Osswald H.
    J Biol Chem; 2007 Feb 02; 282(5):3347-56. PubMed ID: 17138562
    [Abstract] [Full Text] [Related]

  • 20. Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.
    Hambrock A, Löffler-Walz C, Quast U.
    Br J Pharmacol; 2002 Aug 02; 136(7):995-1004. PubMed ID: 12145099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.